The Staying Power of Small Molecules
We asked the 2026 Power List whether newer modalities have eclipsed small molecules – and where the traditional mainstay still wins
10/08/2026
4 min read
False
Advertisement
Related Content
Biopharma
Drug Delivery
Development & Clinical
Staying the Course: Sitting Down With Mike Cooke
October 29, 2026
9 min read
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
Biopharma
Interviews
Sitting Down With
Video: Leading the Alpha Charge – with Øystein Soug
October 28, 2026
1 min read
From the Norwegian Air Force to alpha-emitting radiopharmaceuticals, Øystein Soug has taken the unconventional route to biotech leadership
Cell & Gene
Business & Trends
Power List
Surviving the Squeeze
October 26, 2026
4 min read
The 2026 Power List discuss strategies for navigating today’s funding landscape in cell and gene therapy
Cell & Gene
Development & Clinical
Technology & Manufacturing
Live Roundtable: What Is the Biggest Bottleneck Holding Back Cell and Gene Therapy?
October 23, 2026
1 min read
Industry leaders debate the manufacturing, regulatory, financial, and commercial barriers preventing advanced therapies from reaching more patients